ICU sedation, delirium & recovery

Efficacy and safety of oliceridine versus remifentanil for analgesia in mechanically ventilated critically ill adults (CO-ROAM): a multicenter, assessor-blinded, non-inferiority randomized controlled trial

Intensive Care MedPublished multicentre, assessor- and patient-blinded, non-inferiority randomised controlled trial

Primary result · Time in target analgesic range (TTR)Result — go to the resultAbsolute difference 3.7% 95% CI −0.3 to 5.7%

Authors' conclusion

Oliceridine provides non-inferior analgesia to remifentanil with a more favourable respiratory safety profile and lower costs in critically ill adults.

Study context

Population
Adults receiving invasive mechanical ventilation (IMV) in 19 intensive care units (ICUs) in Chinamodified intention-to-treat population, of 307 randomised patients
Participants
304 adults
Comparison
Oliceridine or remifentanil, titrated to a Critical-Care Pain Observation Tool score below 3
  • Oliceridinen = 151
  • Remifentaniln = 153reference
Primary endpoint
Time in target analgesic range (TTR)
Methodological detailsmodified intention-to-treat population
  • Modified intention-to-treat population

Primary result

Time in target analgesic range (TTR)

Absolute difference

3.7%

95% CI −0.3 to 5.7%

By group

Oliceridinevs remifentanil
absolute difference 3.7% (95% CI −0.3 to 5.7%)

As reported in the abstract

Further findings

Analgesic-sedation costs

Lower with oliceridine

IMV duration, ICU stay, and 28-day mortality

Did not differ

Subgroup analyses (subgroup)

Nominal ADR benefit in patients with Acute Physiology and Chronic Health Evaluation II > 17
Larger nominal TTR difference in those without acute respiratory distress syndrome

Safety

Events per 100 patient-days

OutcomeOliceridineRemifentanilIRR (95% CI)P value
Mild-to-moderate adverse drug reactions (ADRs)15.922.20.72 (0.52–1.00)P = 0.049

Respiratory depression during the study period · lower with oliceridine

P = 0.015

Post-extubation respiratory depression · lower with oliceridine

P = 0.005

Original publication

Efficacy and safety of oliceridine versus remifentanil for analgesia in mechanically ventilated critically ill adults (CO-ROAM): a multicenter, assessor-blinded, non-inferiority randomized controlled trial. Intensive Care Med. Published 10 November 2026. doi:10.1007/s00134-026-08643-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.